NCT03856216 2025-10-16Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell TransplantationM.D. Anderson Cancer CenterPhase 2 Terminated15 enrolled